Skip to main navigation Skip to search Skip to main content

Standardized Treatment Strategy for Depressive Disorder

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

22 Scopus citations

Abstract

The treatment strategies of depressive disorder include pharmacological treatment, psychotherapy, and physical therapy (electroconvulsive therapy [ECT], transcranial magnetic stimulation [TMS], etc.). The updated CANMAT guidelines recommended the most second-generation antidepressants as first-line treatments for patients with a major depressive disorder (MDD) of moderate or greater severity. Before antidepressant treatment, comprehensive assessment and safety monitoring are necessary. The application of measurement-based care in the diagnosis and treatment of depression would better ensure that enough dosage and response of antidepressant is achieved at each key point, and the final outcome of disease is improved. It is recommended that antidepressant is used with monotherapy in patients with depression. Antidepressants of different types and different mechanisms could be combined to improve the efficacy for patients with treatment-resistant depression (TRD). To prevent the relapse and recurrence of disease, the long-term treatment comprised of acute treatment, consolidation treatment, and maintenance treatment must be considered for all patients.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer
Pages193-199
Number of pages7
DOIs
StatePublished - 2019
Externally publishedYes

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1180
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Keywords

  • Depressive disorder
  • Pharmacology
  • Standardized
  • Treatment

Fingerprint

Dive into the research topics of 'Standardized Treatment Strategy for Depressive Disorder'. Together they form a unique fingerprint.

Cite this